Arlington Capital Partners

Arlington Capital Partners is a Washington DC private equity firm specialising in regulated industries, with over $14bn in committed capital across seven funds and roughly 200 transactions since 1999. Fund VI closed at $3.8bn in 2024 and Fund VII at $6bn is now deploying. The firm runs four verticals: aerospace and defence, government services and technology, healthcare and business services. Portfolio includes Verus Aerospace, Stellant Systems (sold to TransDigm for $960m), GRVTY and AVS Bio.